David C. Karli interviews Brad Layzell, CEO of PX3 Sports Sciences. PX3 is an innovative breathing orthotic that has been in development in multiple sectors, including sports medicine/injury prevention, wellness, fitness, neurosciences, sleep and human performance sectors. PX3 orthotics are worn by many professional and elite level athletes. Brad discusses PX3 company development from an entrepreneur perspective and the challenges associated with developing a disruptive technology. PX3 products are positioned for growth and significant commercialization and sales with a sound R&D platform and IP portfolio.
Get in contact with David C. Karli through his website, LinkedIn, and learn more about Greyledge Technologies here: